Lupin launches Mirabegron Extended-Release Tablets in the US
Mirabegron Extended-Release Tablets, 50 mg had estimated annual sales of $ 1,600 million in the US (IQVIA MAT July 2024)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mirabegron extended-release tablets
Zydus launches Mirabegron ER tablets in US
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
US FDA approves Mirabegron extended-release tablets by Zydus
Mirabegron is indicated for the treatment of Over Active Bladder (OAB) with symptoms of urge urinary incontinence, urgency and…